Alnylam Pharmaceuticals
ALNY
#624
Rank
C$46.14 B
Marketcap
$356.41
Share price
-0.16%
Change (1 day)
70.65%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company